Merck KGaA
MKGAF
$145.36
-$2.55-1.72%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -0.24% | 0.50% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.24% | 0.50% | |||
| Cost of Revenue | 4.18% | 2.29% | |||
| Gross Profit | -3.22% | -0.67% | |||
| SG&A Expenses | 8.93% | -2.82% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -296.50% | -62.89% | |||
| Total Operating Expenses | -3.43% | -6.60% | |||
| Operating Income | 11.90% | 41.30% | |||
| Income Before Tax | -24.70% | 35.71% | |||
| Income Tax Expenses | -41.24% | 31.08% | |||
| Earnings from Continuing Operations | -20.00% | 37.09% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 3.04% | -253.21% | |||
| Net Income | -20.06% | 36.13% | |||
| EBIT | 11.90% | 41.30% | |||
| EBITDA | 2.35% | 27.35% | |||
| EPS Basic | -20.03% | 35.70% | |||
| Normalized Basic EPS | 25.11% | 34.12% | |||
| EPS Diluted | -20.03% | 35.70% | |||
| Normalized Diluted EPS | 25.11% | 34.12% | |||
| Average Basic Shares Outstanding | -0.03% | 0.32% | |||
| Average Diluted Shares Outstanding | -0.03% | 0.32% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
